Distinct roles of miR-34 family members on suppression of lung squamous cell carcinoma
miR-34, whose mimic was used on phase I clinical trial, has been extensively reported since its dysfunction in various cancers including non-small-cell lung cancer (NSCLC). However, the roles of miR-34 family members in the progression of lung squamous carcinoma (SCC) in patients who have occupation...
Main Authors: | Dangze Sun, Yao Wu, Shanshan Zhang, Yaxuan Han, Jinglong Shen, Wenhao Zheng, Lin Wei, Yugang Liu, Leipeng Ren, Zhenning Gu, You Liu, Shuhui Liu, Chao Ding |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-10-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332221007496 |
Similar Items
-
MiR-34b is associated with clinical outcome in triple-negative breast cancer patients
by: Svoboda Marek, et al.
Published: (2012-03-01) -
miR-34 – A microRNA Replacement Therapy Is Headed to the Clinic
by: Andreas G Bader
Published: (2012-07-01) -
Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF
by: Roy Sanchita, et al.
Published: (2012-09-01) -
Posttranscriptional deregulation of Src due to aberrant miR34a and miR203 contributes to gastric cancer development
by: Qiang Hao, et al.
Published: (2013-06-01) -
Multifunctional Roles of miR-34a in Cancer: A Review with the Emphasis on Head and Neck Squamous Cell Carcinoma and Thyroid Cancer with Clinical Implications
by: David Kalfert, et al.
Published: (2020-08-01)